col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Avens Publishing Group

18 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Journal of Geriatrics and Palliative Care 2021―Dec―21 COVID-19 Vaccination with Special Reference to Adenoviral Vectors, Clotting Disorders and Old Age SV Jargin
2 [GO] Journal of Surgery 2021―May―20 General Surgery during Pandemic Era - Evolving Strategies: A Cohort Study from a Tertiary Care Centre in North India R Wadhawan
3 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Potential for the Use of Adamantanes for the Prevention and Treatment of the Neurological Complications of COVID-19 Roger F Butterworth
4 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Potential for the Repurposing of Adamantanes for the Treatment of Covid-19 Roger F Butterworth
5 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Repurposing of Adamantanes with Transmitter Receptor Antagonist Properties for the Prevention/Treatment of COVID-19 SR Brenner
6 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Lysosomotropic Action of Amantadine: Basis for Treatment of COVID-19 SP Smieszek
7 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Adamantanes for the Prevention of COVID-19: A Review of Case Reports Cortes A Borra
8 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Repurposing of Adamantanes for the Treatment of COVID-19: Rationale and Perspectives Roger F Butterworth
9 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis Aranda Abreu GE
10 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Amantadine for the Treatment of SARS-Cov-2: Case Report GE Aranda-Abreu
11 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 Lysosomotropic Action of Amantadine: Basis for Treatment of COVID-19
12 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 Potential for the Use of Adamantanes for the Prevention and Treatment of the Neurological Complications of COVID-19
13 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 Adamantanes for the Prevention of COVID-19: A Review of Case Reports
14 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 Repurposing of Adamantanes for the Treatment of COVID-19: Rationale and Perspectives
15 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis
16 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 Amantadine for the Treatment of SARS-Cov-2: Case Report
17 [GO] Journal of Oral Biology 2020―Dec―05 pH, Presents a New Weapon in the Battle Against COVID-19
18 [GO] Journal of Parkinson’s Disease and Alzheimer’s Disease 2020―Dec―05 Amantadine Treatment for Parkinson’s Disease during COVID-19: Bimodal Action Targeting Viral Replication and the NMDA Receptor
 [1] 

18 Results       Page 1




[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.006 sec